Carboxyamidotriazole orotate in combination with temozolomide, with or without radiotherapy, produced positive safety and efficacy results in a phase Ib study of patients with glioblastoma or anaplastic gliomas.
Original Article: Carboxyamidotriazole Orotate Shows Promising Activity in Brain Cancers